Development of Lipidoid–siRNA Formulations for Systemic Delivery to the Liver
Top Cited Papers
Open Access
- 1 May 2009
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 17 (5) , 872-879
- https://doi.org/10.1038/mt.2009.36
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transferGene Therapy, 2008
- RNAi-mediated gene silencing in non-human primatesNature, 2006
- Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acidsJournal of Controlled Release, 2005
- Sequence-Specific Knockdown of EWS-FLI1 by Targeted, Nonviral Delivery of Small Interfering RNA Inhibits Tumor Growth in a Murine Model of Metastatic Ewing's SarcomaCancer Research, 2005
- Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivoProceedings of the National Academy of Sciences, 2005
- Intracellular trafficking of nonviral vectorsGene Therapy, 2005
- Potent and persistent in vivo anti-HBV activity of chemically modified siRNAsNature Biotechnology, 2005
- Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptorsNature Biotechnology, 2005
- Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNANature Biotechnology, 2005
- Gene therapy put on hold as third child develops cancerNature, 2005